vs
Dominari Holdings Inc.(DOMH)与IRONWOOD PHARMACEUTICALS INC(IRWD)财务数据对比。点击上方公司名可切换其他公司
IRONWOOD PHARMACEUTICALS INC的季度营收约是Dominari Holdings Inc.的1.6倍($47.7M vs $30.1M),IRONWOOD PHARMACEUTICALS INC净利率更高(-4.8% vs -438.1%,领先433.3%),Dominari Holdings Inc.同比增速更快(220.4% vs -47.3%),过去两年Dominari Holdings Inc.的营收复合增速更高(369.1% vs -20.2%)
Ironwood制药公司是一家上市制药企业,其前身为Microbia公司,专注于制药领域相关业务研发与运营,面向市场开发各类创新医药产品,满足未被充分满足的临床医疗需求。
DOMH vs IRWD — 直观对比
营收规模更大
IRWD
是对方的1.6倍
$30.1M
营收增速更快
DOMH
高出267.7%
-47.3%
净利率更高
IRWD
高出433.3%
-438.1%
两年增速更快
DOMH
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $30.1M | $47.7M |
| 净利润 | $-131.8M | $-2.3M |
| 毛利率 | — | — |
| 营业利润率 | -8.9% | 14.3% |
| 净利率 | -438.1% | -4.8% |
| 营收同比 | 220.4% | -47.3% |
| 净利润同比 | -12426.2% | -200.9% |
| 每股收益(稀释后) | $-6.94 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DOMH
IRWD
| Q4 25 | $30.1M | $47.7M | ||
| Q3 25 | $50.8M | $122.1M | ||
| Q2 25 | $34.1M | $85.2M | ||
| Q1 25 | $8.1M | $41.1M | ||
| Q4 24 | $9.4M | $90.5M | ||
| Q3 24 | $4.0M | $91.6M | ||
| Q2 24 | $6.2M | $94.4M | ||
| Q1 24 | $1.4M | $74.9M |
净利润
DOMH
IRWD
| Q4 25 | $-131.8M | $-2.3M | ||
| Q3 25 | $125.2M | $40.1M | ||
| Q2 25 | $16.6M | $23.6M | ||
| Q1 25 | $-32.5M | $-37.4M | ||
| Q4 24 | $1.1M | $2.3M | ||
| Q3 24 | $-4.2M | $3.6M | ||
| Q2 24 | $-6.1M | $-860.0K | ||
| Q1 24 | $-5.4M | $-4.2M |
营业利润率
DOMH
IRWD
| Q4 25 | -8.9% | 14.3% | ||
| Q3 25 | -3.1% | 61.8% | ||
| Q2 25 | -57.0% | 53.2% | ||
| Q1 25 | -394.6% | -70.7% | ||
| Q4 24 | 0.4% | 34.8% | ||
| Q3 24 | -79.1% | 28.0% | ||
| Q2 24 | -44.3% | 26.5% | ||
| Q1 24 | -205.2% | 14.7% |
净利率
DOMH
IRWD
| Q4 25 | -438.1% | -4.8% | ||
| Q3 25 | 246.4% | 32.8% | ||
| Q2 25 | 48.7% | 27.7% | ||
| Q1 25 | -400.5% | -90.9% | ||
| Q4 24 | 11.4% | 2.5% | ||
| Q3 24 | -104.2% | 4.0% | ||
| Q2 24 | -99.1% | -0.9% | ||
| Q1 24 | -398.0% | -5.6% |
每股收益(稀释后)
DOMH
IRWD
| Q4 25 | $-6.94 | $0.01 | ||
| Q3 25 | $7.27 | $0.23 | ||
| Q2 25 | $1.12 | $0.14 | ||
| Q1 25 | $-3.02 | $-0.23 | ||
| Q4 24 | $0.21 | $0.03 | ||
| Q3 24 | $-0.67 | $0.02 | ||
| Q2 24 | $-1.01 | $-0.01 | ||
| Q1 24 | $-0.91 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $215.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $69.4M | $-261.8M |
| 总资产 | $112.9M | $396.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DOMH
IRWD
| Q4 25 | $80.5M | $215.5M | ||
| Q3 25 | $176.2M | $140.4M | ||
| Q2 25 | $28.2M | $92.9M | ||
| Q1 25 | $18.9M | $108.5M | ||
| Q4 24 | $8.2M | $88.6M | ||
| Q3 24 | $7.2M | $88.2M | ||
| Q2 24 | $12.1M | $105.5M | ||
| Q1 24 | $7.1M | $121.5M |
总债务
DOMH
IRWD
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
股东权益
DOMH
IRWD
| Q4 25 | $69.4M | $-261.8M | ||
| Q3 25 | $210.2M | $-264.2M | ||
| Q2 25 | $88.6M | $-308.2M | ||
| Q1 25 | $42.4M | $-334.1M | ||
| Q4 24 | $39.9M | $-301.3M | ||
| Q3 24 | $38.3M | $-311.3M | ||
| Q2 24 | $42.4M | $-321.7M | ||
| Q1 24 | $47.7M | $-330.5M |
总资产
DOMH
IRWD
| Q4 25 | $112.9M | $396.9M | ||
| Q3 25 | $223.4M | $396.1M | ||
| Q2 25 | $109.3M | $342.9M | ||
| Q1 25 | $52.3M | $327.2M | ||
| Q4 24 | $47.1M | $350.9M | ||
| Q3 24 | $43.4M | $389.5M | ||
| Q2 24 | $49.1M | $395.6M | ||
| Q1 24 | $52.2M | $438.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $22.7M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | — | $74.6M |
| 自由现金流率自由现金流/营收 | — | 156.3% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $127.0M |
8季度趋势,按日历期对齐
经营现金流
DOMH
IRWD
| Q4 25 | $22.7M | $74.6M | ||
| Q3 25 | $-4.9M | $47.6M | ||
| Q2 25 | $-353.0K | $-15.1M | ||
| Q1 25 | $1.2M | $20.0M | ||
| Q4 24 | $-16.7M | $15.2M | ||
| Q3 24 | $-4.7M | $9.9M | ||
| Q2 24 | $1.4M | $33.5M | ||
| Q1 24 | $-8.6M | $45.0M |
自由现金流
DOMH
IRWD
| Q4 25 | — | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $33.4M | ||
| Q1 24 | — | $44.9M |
自由现金流率
DOMH
IRWD
| Q4 25 | — | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | — | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.8% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 60.0% |
资本支出强度
DOMH
IRWD
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
现金转化率
DOMH
IRWD
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | 1.19× | ||
| Q2 25 | -0.02× | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
IRWD
暂无分部数据